ATE442360T1 - 5-substituierte pyrimidinderivate eines konformatiosfestgelegten nukleosidanalogen - Google Patents
5-substituierte pyrimidinderivate eines konformatiosfestgelegten nukleosidanalogenInfo
- Publication number
- ATE442360T1 ATE442360T1 AT01957228T AT01957228T ATE442360T1 AT E442360 T1 ATE442360 T1 AT E442360T1 AT 01957228 T AT01957228 T AT 01957228T AT 01957228 T AT01957228 T AT 01957228T AT E442360 T1 ATE442360 T1 AT E442360T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrimidine derivatives
- substituted pyrimidine
- conformatio
- analogo
- nucleoside
- Prior art date
Links
- -1 5-SUBSTITUTED PYRIMIDINE Chemical class 0.000 title abstract 2
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title abstract 2
- 239000002777 nucleoside Substances 0.000 title 1
- 150000003833 nucleoside derivatives Chemical class 0.000 title 1
- 241000700584 Simplexvirus Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000845 uracil-1-yl group Chemical group [*]N1C(=O)N([H])C(=O)C([H])=C1[H] 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 125000000847 cytosin-1-yl group Chemical group [*]N1C(=O)N=C(N([H])[H])C([H])=C1[H] 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229940127073 nucleoside analogue Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22093400P | 2000-07-26 | 2000-07-26 | |
| PCT/US2001/023246 WO2002008204A2 (en) | 2000-07-26 | 2001-07-24 | 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE442360T1 true ATE442360T1 (de) | 2009-09-15 |
Family
ID=22825624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01957228T ATE442360T1 (de) | 2000-07-26 | 2001-07-24 | 5-substituierte pyrimidinderivate eines konformatiosfestgelegten nukleosidanalogen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7009050B2 (de) |
| EP (1) | EP1305296B9 (de) |
| AT (1) | ATE442360T1 (de) |
| AU (2) | AU2001278993B2 (de) |
| CA (1) | CA2417251C (de) |
| CY (1) | CY1109592T1 (de) |
| DE (1) | DE60139875D1 (de) |
| DK (1) | DK1305296T3 (de) |
| ES (1) | ES2332580T3 (de) |
| PT (1) | PT1305296E (de) |
| WO (1) | WO2002008204A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001051490A1 (en) * | 2000-01-14 | 2001-07-19 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methanocarba cycloalkyl nucleoside analogues |
| WO2006091905A1 (en) * | 2005-02-25 | 2006-08-31 | Gilead Sciences, Inc. | Bicyclo (3.1.0) hexane derivatives as antiviral compounds |
| US20090221523A1 (en) | 2005-05-25 | 2009-09-03 | Tseng Christopher K | North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses |
| EP2507241A1 (de) | 2009-12-02 | 2012-10-10 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Methanocarba adenosin-derivate und dendrimerkonjugate daraus |
| EP3119789B1 (de) | 2014-03-17 | 2020-04-22 | Ionis Pharmaceuticals, Inc. | Bicyclische carbocyclische nukleoside und daraus hergestellte oligomere verbindungen |
| WO2016033164A1 (en) * | 2014-08-26 | 2016-03-03 | Enanta Pharmaceuticals, Inc. | Nucleoside and nucleotide derivatives |
| US10208081B2 (en) | 2014-11-26 | 2019-02-19 | Enanta Pharmaceuticals, Inc. | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof |
| JP7136802B2 (ja) | 2017-04-07 | 2022-09-13 | エナンタ ファーマシューティカルズ インコーポレイテッド | スルホニルカルバマート胆汁酸誘導体の調製のためのプロセス |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69406943T2 (de) * | 1993-09-24 | 1998-05-07 | Us Health | Konformationell festgelegte nukleosidanaloge |
| WO1998005662A1 (en) * | 1996-08-07 | 1998-02-12 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Conformationally locked nucleoside analogs as antiherpetic agents |
| US5840728A (en) * | 1996-08-07 | 1998-11-24 | United States Of America As Represented By The Department Of Health And Human Services | Conformationally locked nucleoside analogs as antiherpetic agents |
-
2001
- 2001-07-24 DK DK01957228T patent/DK1305296T3/da active
- 2001-07-24 WO PCT/US2001/023246 patent/WO2002008204A2/en active Application Filing
- 2001-07-24 DE DE60139875T patent/DE60139875D1/de not_active Expired - Lifetime
- 2001-07-24 CA CA2417251A patent/CA2417251C/en not_active Expired - Lifetime
- 2001-07-24 AU AU2001278993A patent/AU2001278993B2/en not_active Expired
- 2001-07-24 PT PT01957228T patent/PT1305296E/pt unknown
- 2001-07-24 ES ES01957228T patent/ES2332580T3/es not_active Expired - Lifetime
- 2001-07-24 AU AU7899301A patent/AU7899301A/xx active Pending
- 2001-07-24 EP EP01957228A patent/EP1305296B9/de not_active Expired - Lifetime
- 2001-07-24 AT AT01957228T patent/ATE442360T1/de active
-
2003
- 2003-01-15 US US10/346,762 patent/US7009050B2/en not_active Expired - Lifetime
-
2009
- 2009-11-09 CY CY20091101159T patent/CY1109592T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1305296A2 (de) | 2003-05-02 |
| CA2417251A1 (en) | 2002-01-31 |
| WO2002008204A3 (en) | 2002-05-16 |
| ES2332580T3 (es) | 2010-02-09 |
| WO2002008204A2 (en) | 2002-01-31 |
| AU7899301A (en) | 2002-02-05 |
| DE60139875D1 (de) | 2009-10-22 |
| AU2001278993B2 (en) | 2006-08-31 |
| PT1305296E (pt) | 2009-11-16 |
| CA2417251C (en) | 2012-11-13 |
| EP1305296B9 (de) | 2010-04-07 |
| EP1305296B1 (de) | 2009-09-09 |
| US20050282837A1 (en) | 2005-12-22 |
| US7009050B2 (en) | 2006-03-07 |
| DK1305296T3 (da) | 2009-12-14 |
| CY1109592T1 (el) | 2014-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
| PA8588501A1 (es) | Derivados antivirales de nucleósidos | |
| BRPI0410409B8 (pt) | artigo absorvente descartável e processo de formação do mesmo | |
| HRP20041177B1 (hr) | Mikrobicidni pirimidini ili triazini za prevenciju prijenosa hiv seksualnim putem | |
| TR199800436A2 (xx) | Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�. | |
| ATE245641T1 (de) | Antivirale pyrimidinderivate | |
| BRPI0410412A (pt) | artigo absorvente descartável possuindo uma faixa de cintura integral | |
| BRPI0909556B8 (pt) | artigo absorvente para uso pessoal em torno da cintura de um usuário | |
| NZ601486A (en) | 2',4'-substituted nucleosides as antiviral agents | |
| CA2577745A1 (en) | Hcv inhibiting bi-cyclic pyrimidines | |
| EA200601263A1 (ru) | Фосфорсодержащие производные пурина (варианты), лекарственное средство на их основе для воздействия на вирус папилломы человека и на опухолевые клетки (варианты) | |
| MY140819A (en) | Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae | |
| UY26758A1 (es) | Agentes antivirales de imidazopiridina e imidazopirimidina | |
| ATE512973T1 (de) | Nukleosid-arylphosphoramidate und ihre verwendung als antivirale mittel zur behandlung von hepatitis-c-virus | |
| CO5070667A1 (es) | Articulo para el cuidado personal con apendice | |
| BRPI0107403B8 (pt) | Compostos de n-(5,7-dimetóxi[1,2,4]triazolo[1,5-alfa]pirimidin-2-il) arilsulfonamida e o uso dos mesmos como herbicidas. | |
| ATE442360T1 (de) | 5-substituierte pyrimidinderivate eines konformatiosfestgelegten nukleosidanalogen | |
| BRPI0909539B8 (pt) | artigo absorvente de uso pessoal com aba de ajuste na cintura | |
| EA200900140A1 (ru) | Подгузник для взрослых | |
| TR200402534T4 (tr) | Viral enfeksiyonların tedavisinde yararlı oksazinokuinolonlar. | |
| SV2003000995A (es) | Nuevas arilsulfonamidas como agentes antivirales ref. lea35214-sv | |
| PT1242119E (pt) | Combinacoes para o tratamento de infeccoes por virus adn incluindo um diuretico de ansa e um glicosido cardiotonico | |
| WO2001006986A3 (en) | 5-(e)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use | |
| RU97110670A (ru) | Композиция для предотвращения и лечения вич-1 инфекции, ее применение | |
| KR900018093A (ko) | 2',3'-디데히드로-2',3'-디데옥시뉴클레오사이드류의 전구체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1305296 Country of ref document: EP |